ArticleCureus2026
Comparative Efficacy of Er,Cr:YSGG Laser, Electrolytic Cleaning, and Chlorhexidine for the Decontamination of Sandblasted, Large-Grit, Acid-Etched (SLA) Implant Surfaces: An In Vitro Controlled Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPredictable decontamination of exposed implant surfaces remains difficult to achieve in peri-implantitis therapy. Rough sandblasted, large-grit, acid-etched (SLA) surfaces and implant thread geometry may promote biofilm retention and limit the effectiveness of chemical antiseptics and mechanical instrumentation.
objectiveThis controlled in vitro study compared the antimicrobial efficacy of three clinically relevant decontamination approaches: 0.12% chlorhexidine (CHX), GalvoSurge electrolytic cleaning, and erbium, chromium: yttrium-scandium-gallium-garnet (Er,Cr:YSGG) laser irradiation against
methodsForty-eight Straumann SLA tissue-level implants were fixed in custom three-dimensional (3D)-printed peri-implant defect models and individually contaminated with
resultsMean log10(CFU/implant) values were highest in the untreated control group (5.09 ± 0.33), followed by CHX (4.03 ± 0.12), GalvoSurge (3.77 ± 0.25), and Er,Cr:YSGG laser treatment (2.52 ± 0.39). The corresponding reductions relative to control were approximately 1.06 log10 for CHX, 1.32 log10 for GalvoSurge, and 2.57 log10 for laser treatment. Statistical analysis demonstrated a significant treatment effect (p < 0.001), with laser irradiation achieving the greatest reduction in viable bacterial counts under the tested conditions.
conclusionAll active protocols reduced viable
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.